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Abstract   19 
Addition of external carbon sources to post-denitrification systems is frequently used in wastewater 20 
treatment plants to enhance nitrate removal. However, little is known about the fate of 21 
micropollutants in post-denitrification systems and the influence of external carbon dosing on their 22 
removal. In this study, we assessed the effects of two different types and availability of commonly 23 
used carbon sources —methanol and ethanol— on the removal of micropollutants. Two laboratory-24 
scale moving bed biofilm reactors (MBBRs), containing AnoxKaldnes K1 carriers with acclimated 25 
biofilm from full-scale systems, were operated in continuous-flow using wastewater dosed with 26 
methanol and ethanol. Batch experiments with 22 spiked pharmaceuticals were performed to assess 27 
removal kinetics. Acetyl-sulfadiazine, atenolol, citalopram, propranolol and trimethoprim were 28 
easily biotransformed in both MBBRs (biotransformations rate constants kbio between 1.2 and 12.9 29 
L gbiomass
-1
 d
-1
), 13 compounds were moderately biotransformed (rate constants between 0.2 and 2 L 30 
gbiomass
-1
 d
-1
) and 4 compounds were recalcitrant. The methanol-dosed MBBR showed higher kbio 31 
(e.g., 1.5 to 2.5-fold) than in the ethanol-dosed MBBR for 9 out of the 22 studied compounds, equal 32 
kbio for 10 compounds, while 3 compounds (i.e., targeted sulfonamides) were biotransformed faster 33 
in the ethanol-dosed MBBR. While biotransformation of most of the targeted compounds followed 34 
first-order kinetics, removal of venlafaxine, carbamazepine, sulfamethoxazole and sulfamethizole 35 
could be described with a cometabolic model. Analyses of the microbial composition in the 36 
biofilms using 16S rRNA amplicon sequencing revealed that the methanol-dosed MBBR contained 37 
higher microbial richness than the one dosed with ethanol, suggesting that improved 38 
biotransformation of targeted compounds could be associated with higher microbial richness. 39 
During continuous-flow operation, at conditions representative of full-scale denitrification systems 40 
(hydraulic residence time = 2 h), the removal efficiencies of micropollutants were below 35% in 41 
both MBBRs, with the exception of atenolol and trimethoprim (>80%). Overall, this study 42 
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demonstrated that MBBRs used for post–denitrification could be optimized to enhance the 43 
biotransformation of a number of micropollutants by accounting for optimal carbon sources and 44 
extended residence time. 45 
  46 
 4 
 
1. Introduction  47 
Currently used biological processes in conventional wastewater treatment plants (WWTPs) are 48 
designed to remove organic carbon and nutrients (nitrogen and phosphorus). As organic 49 
micropollutants are gaining attention due to the associated environmental risks (Daughton and 50 
Ternes, 1999; Plósz et al., 2013), the optimization of biological processes for removal of 51 
micropollutants during wastewater treatment is crucial (Joss et al., 2008). Micropollutants (e.g., 52 
pharmaceuticals and personal care products) are generally recognized as non-growth substrates 53 
(secondary substrates), as they are present in wastewater in too low concentrations (ng L
-1
 to µg L
-1
) 54 
to support biomass growth (Fischer and Majewsky, 2014; Rittmann, 1992). Therefore, biological 55 
transformation of micropollutants is mainly the result of cometabolic mechanisms, whereby the 56 
removal of non-growth substrates (micropollutants) requires the presence of primary substrates (i.e., 57 
COD, nutrients) to support biomass growth (Criddle, 1993; Rittmann, 1992). In cometabolism, the 58 
biotransformation of micropollutant is typically catalyzed by non-specific enzymes (e.g., mono- or 59 
di-oxygenases, N-acetyltransferases, hydrolases) or by cofactors produced during the microbial 60 
conversion of the primary substrate (Criddle, 1993; Fischer and Majewsky, 2014). Nevertheless, the 61 
interaction between primary substrate and micropollutants is complex and not completely 62 
understood. In fact, the presence of primary substrate has been reported to either enhance the 63 
removal of micropollutants, e.g., by regenerating reductants such as NAD(P)H under aerobic 64 
conditions (Alvarez-Cohen and Speitel, 2001; Liu et al., 2015), or decrease it, due to competitive 65 
enzyme inhibition (Fischer and Majewsky, 2014; Plósz et al., 2010).  66 
 67 
Recent studies have proposed biofilm systems, e.g., moving bed biofilm reactors (MBBR), as a 68 
promising alternative to activated sludge systems (CAS) with respect to the attenuation of 69 
micropollutants (Escolà Casas et al., 2015a; Falås et al., 2012; Hapeshi et al., 2013; Torresi et al., 70 
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2016). In general, most of the studies concerning the removal of micropollutants during biological 71 
wastewater treatment have focused on aerobic systems, whereas only little information is available 72 
for anoxic denitrifying conditions: Plósz et al., 2010; Su et al., 2015; Falås et al. 2013, Suárez et al., 73 
2010. While pharmaceuticals such as diclofenac, metoprolol, erythromycin and roxithromycin were 74 
found to be transformed mainly under aerobic conditions in activated sludge using synthetic 75 
wastewater (Suárez et al., 2010) and in hybrid biofilm-activated sludge processes (Falås et al., 76 
2013), some of the investigated chemicals had similar (i.e., bezafibrate, atenolol, clarithromycin and 77 
N
4
-acetylsulfamethoxazole) or higher (i.e., levetiracetam) biotransformation under anoxic 78 
conditions than under aerobic ones (Falås et al., 2013). Hence, anoxic biological processes in 79 
conventional WWTPs should be considered as a potential step to optimize removal of 80 
micropollutants.  81 
The type of carbon source is known to have a strong impact on the structure of denitrifying 82 
microbial communities and thus on denitrification efficiency (Baytshtok et al., 2009; Hagman et al., 83 
2007; Lu et al., 2014). This has specific relevance to post-denitrification reactors in full-scale 84 
WWTPs, where nitrate removal is achieved by dosing external carbon sources such as methanol and 85 
ethanol (Louzeiro et al, 2002; Santos et al., 2001). Methanol and ethanol are metabolized by 86 
denitrifying bacteria through different pathways. Methanol undergoes the metabolic reaction of 87 
single-carbon compounds, which is exclusive to methylotrophs because of their unique key enzyme 88 
(methanol dehydrogenase) that catalyzes the oxidization of methanol to formaldehyde (Anthony et 89 
al., 1982, 2011). Instead, ethanol is easily converted by bacterial cells to Acetyl-CoA before 90 
entering the glyoxylate cycle (Anthony et al., 2011). Thus, microbial communities in post-91 
denitrifying systems using either of these carbon sources may be fundamentally different and 92 
potentially exhibit a different biodiversity and functionality with more or less microbial specialists 93 
able to biotransform organic micropollutants. Additionally, biodiversity in terms of species richness 94 
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(the number of species) and evenness (the relative abundance of the species) (Wittebolle et al., 95 
2009) was shown to positively associate with the biotransformation of a number of micropollutants 96 
in aerobic activated sludge (Johnson et al., 2015; Stadler and Love, 2016) and nitrifying MBBRs 97 
(Torresi et al., 2016). Further investigation of the impact of biodiversity in different biological 98 
treatment systems seems thus required. 99 
In this study, we evaluated the elimination of selected micropollutants (i.e., pharmaceuticals) in 100 
laboratory-scale post-denitrifying MBBRs dosed with methanol or ethanol. Biotransformation 101 
kinetics and removal efficiencies were assessed through targeted batch experiments and during 102 
continuous-flow MBBR operation, respectively. The objectives of our study were: (i) to investigate 103 
the impact of different types of external carbon sources (methanol and ethanol) for post-104 
denitrification on micropollutant biotransformation; (ii) to assess the structure of the denitrifying 105 
microbial community of MBBR biofilms, following continuous dosing with either methanol or 106 
ethanol; and (iii) to evaluate the influence of organic substrate availability on the transformation of 107 
micropollutants and the related mechanisms, i.e. competitive inhibition and cometabolic 108 
enhancement.   109 
 110 
2. Materials and Methods 111 
 112 
2.1 Description of the post-denitrifying systems 113 
Two Swedish WWTPs, i.e., Sjölunda and Klagshamn are currently dosing methanol or ethanol, 114 
respectively, as external carbon source in two-stage post-denitrification MBBRs. Thus, two 115 
laboratory-MBBRs were built to resemble such post-denitrification stages, using carriers 116 
(AnoxKaldnes K1) from the first post-denitrification tank of the respective WWTPs already adapted 117 
to methanol and ethanol dosing. The WWTPs are described in Section S1 of the SI (Supporting 118 
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Information). Both laboratory-MBBRs (1 L) were operated in continuous feeding of the same 119 
wastewater, which was collected after the (aerobic) nitrification step (trickling filter) of Sjölunda 120 
WWTP (Lund, Sweden). Thus, during continuous-flow operation, only the indigenous nitrate and 121 
nitrite present in the wastewater (averaged concentration of 13 and 1.2 mg L
-1
 respectively) were 122 
used for denitrification. The filling rate of both reactors was 40%, giving a surface of 0.2 m
2
. The 123 
amount of indigenous micropollutants in the reactor influents (consisting in the collected 124 
wastewater and feed containing carbon-source) was analyzed. Twelve compounds were quantified 125 
giving concentrations between 0.04 µg L
-1
 (trimethoprim) and 78 µg L
-1
 (iohexol). Complete details 126 
of these results are given in Table S6 (SI).  127 
 128 
The reactors were continuously flushed with nitrogen gas and stirred for the mixing of the carriers 129 
and to strip eventual residual dissolved oxygen. Both reactors were kept at 15°C using a water bath. 130 
The feed wastewater was mixed and kept at 4°C during the whole experiment. Phosphate was added 131 
to the feed to reach a concentration of 0.5 mg L
-1
 to ensure biofilm growth on the carriers. 132 
Micropollutant removal and denitrification rates in MBBRs were assessed in two main experiments: 133 
(i) batch conditions (24 h) and (ii) continuous-flow operation (2 months). The carbon availability of 134 
ethanol and methanol into the two MBBRs was defined as the ratio between the influent loading of 135 
organic carbon (CODadded) and the native loading of nitrate (NO3-Ninfluent) in the wastewater 136 
samples. Optimum CODadded/NO3-Ninfluent ratio (gCOD gN
-1
)
 
for complete denitrification is typically 137 
around 4 (Metcalf & Eddy, 2003). 138 
 139 
2.2 Analytical methods 140 
All the samples taken for analysis of conventional pollutants (NH4
+
-N, NO3
−
-N, NO2
−
-N, soluble 141 
COD and PO3
4-
) in batch and continuous experiments were filtered through 0.45 μm glass fiber 142 
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filters (Sartorius, Göttingen, Germany). Total COD and total nitrogen were analyzed on the 143 
unfiltered sample. All samples were prepared in Hach Lange kits (LCK 303, LCK 339, LCK 341 144 
and LCK 342) and analyzed in a Hach Lange DR2800 spectrophotometer. DO, pH and temperature 145 
in the reactors were measured at each sampling occasion, using a Hach HQ40d multi DO probe and 146 
a HANNA H1991001 pH-meter. The attached biomass concentrations were calculated from the 147 
difference in weight of 3 dried carriers (105 °C for >24 h) before and after biofilm removal (in 2M 148 
H2SO4) with subsequent brushing (see Figure S2 for results), as previously considered (Escolà 149 
Casas et al., 2015a; Falås et al., 2012; Torresi et al., 2016). Samples for micropollutants were frozen 150 
at -20 
o
C prior analysis and analyzed via direct injection using HPLC-MS/MS as described in 151 
Escolà Casas et al. (2015a). Information regarding sample preparation, HPLC, mass spectrometry 152 
data, LOD and LOQ of compounds are shown in Escolà Casas et al. (2015a) and in Section S2 (SI). 153 
 154 
2.3 Chemicals  155 
Twenty-two relevant micropollutants (i.e., pharmaceuticals) were selected for this study. 156 
Information regarding CAS numbers and chemical suppliers is found in the supplementary 157 
information in Escolà Casas et al. (2015b). The pharmaceuticals included: (i) four beta-blockers, 158 
i.e., atenolol, metoprolol, propranolol and sotalol; (ii) five X-ray contrast media, i.e., diatrizoic acid, 159 
iohexol, iopamidol, iopromide, iomeprol; (iii) three sulfonamides, i.e., sulfadiazine, sulfamethizole 160 
and sulfamethoxazole and the metabolite acetyl-sulfadiazine; (iv) three analgesics, i.e., phenazone, 161 
diclofenac and ibuprofen; (v) three anti-epileptics/anti-depressants, i.e., carbamazepine, venlafaxine 162 
and citalopram; (vi) four antibiotics, i.e., erythromycin, clarithromycin, trimethoprim and 163 
roxithromycin. 164 
 165 
 166 
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2.4 Batch experiment 167 
To investigate how the type of dosed carbon source influences the removal of micropollutants in 168 
post-denitrifying MBBR, batch experiments were performed in the same reactors used during 169 
continuous-flow operation. These experiments were conducted after 3.5 months of continuous-flow 170 
operation of the two systems. During the batch experiments, a CODadded/NO3-Ninfluent ratio of 3.4 for 171 
both reactors was adopted to obtain excess concentration of nitrate. Anoxic conditions were 172 
maintained by flushing the reactors with nitrogen gas during the experiment. The feed used for the 173 
batch consisted of the same wastewater used in continuous operation spiked with 239 ± 2 mg 174 
COD L
−1
 of methanol for the methanol-dosed reactor and the same amount of ethanol for the 175 
ethanol-dosed reactor, 70 ± 3 mg NO3-N L
−1
 in form of sodium nitrate and 22 micropollutants with 176 
an initial nominal concentration of 2 μg L−1. The micropollutants were added from a stock solution 177 
(40 mg L
−1
 in methanol). To minimize the increase of COD concentration in the batch feed due to 178 
the methanol from the stock solution, the micropollutant solution was first spiked into an empty 179 
glass beaker and the methanol was let to evaporate for approximately 1 hour. Afterwards, the feed 180 
was added to the beaker containing the micropollutants and mixed to re-dissolve the 181 
micropollutants. The batch experiment lasted 24 hours and samples for conventional and 182 
micropollutants analysis were taken at regular intervals. To keep the biomass concentration constant 183 
during the experiment, three carriers were withdrawn from the reactors each time a sample was 184 
taken for analysis. The pH value in both reactors was continuously measured and adjusted to 7.5 185 
using 1M HCl. The temperature was kept constant at 15°C.  186 
 187 
2.4.1 Denitrification during batch experiment 188 
Denitrification rates normalized on surface area of reactors rNO3,2-N (gNO3,2-N m
-2
 d
−1
) and specific 189 
denitrification rates accounting for the biomass kNO3,2-N (gNO3,2-N gbiomass
-1
 d
−1
) were derived 190 
 10 
 
through linear regression using NO3
−
-N and NO2
−
-N measurements during batch experiment. An 191 
accumulation of nitrite in the systems was noticed (~ 6 mg L
-1
), therefore NO3,2-N utilization curves 192 
accounting also for NO2
−
-N concentration were derived accordingly to Sözen et al. (1998).  193 
 194 
A two step-denitrification activated sludge model (ASM) was used to describe up-take of primary 195 
substrates (i.e., readily soluble biodegradable COD (SS), soluble nitrate (SNO3) and nitrite (SNO2)) 196 
which was extended with the Activated Sludge Model for Xenobiotics ASM-X (Plósz et al., 2012; 197 
Polesel et al., 2016) to determine micropollutant biotransformation rates (Table 1). Readily soluble 198 
biodegradable COD (SS) was determined as the difference between soluble COD (sCOD)—199 
measured during the experiments—and soluble inert COD (SI)—calculated according to Roeleveld 200 
and Van Loosdrecht (2002). The ASM for denitrification was adapted from Pan et al. (2015) and 201 
included two process rate equations with reduction of nitrate to nitrite (R1) and nitrite to nitrogen 202 
(R2) (Table 1). Parameters that could not be identified through model calibration to experimental 203 
results (maximum specific growth rates µH, affinity constants for substrate—KS1 and KS2—and for 204 
nitrogen species—    
  
        
   —) were adopted from literature (Hiatt and Grady, 2008). 205 
Parameters that are known to be sensitive to the experimental data (i.e., heterotrophic yields YH, 206 
anoxic growth factors for the process 1 and 2, ηg1 and ηg2) were calibrated. Definition of the 207 
components and model calibration are presented in Section S3 and Table S1 (SI). The model was 208 
implemented in AQUASIM 2.1d (Reichert et al., 1994) and the parameters were estimated using the 209 
secant method embedded. 210 
 211 
2.4.2 Micropollutants removal kinetics during batch experiment 212 
Model structures to assess biotransformation rate of micropollutants were identified using the ASM-213 
X as modelling framework (Polesel et al., 2016; Plósz et al., 2010, 2012, 2013). The framework 214 
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used in this study is summarized in Table 1 and included processes such as parent compound 215 
retransformation (e.g., deconjugation of human metabolites) (1), biotransformation (2) and 216 
cometabolic biotransformation (in the presence and absence of organic growth substrate) (3). The 217 
effect of diffusion into biofilm on the removal of pharmaceuticals from bulk aqueous phase was 218 
lumped in the biotransformation rate constants, as previously considered by Falås et al. (2012, 219 
2013), Escolá Casas et al. (2015a) and Hapeshi et al. (2013). The cometabolic process was 220 
modelled as proposed by Plósz et al. (2012), using pseudo-first order kinetics with respect to 221 
micropollutant concentration and estimating two biokinetics: (i) the cometabolic biotransformation 222 
rate constant qbio in the presence of the primary substrate and (ii) biotransformation rate constant 223 
kbio in the absence of primary substrate. Accordingly, biotransformation kinetics of the cometabolic 224 
substrate (e.g., micropollutant) depend on the primary substrate concentration (e.g., organic matter 225 
expressed as readily soluble biodegradable COD, SS) considered a co-limiting substrate. In Table 1 226 
CLI and CCJ denote the aqueous concentration (ng L
-1
) of the parent compound and the human 227 
metabolites undergoing deconjugation to the parent compound, respectively. The retransformation 228 
rate constant kDec (L gbiomass
-1
 d
-1
) defines kinetics of retransformation to parent compound. Sorption 229 
processes were also included considering the sorption coefficient KD (L gbiomass
-1
) which was 230 
calibrated using values from previous studies estimated under denitrifying condition when available 231 
(Table S2 in SI). As to the best of our knowledge values of KD were not previously estimated for 232 
biofilm under denitrifying conditions, KD measured for activated sludge were used in this study. 233 
The half-saturation coefficient for SS, (KS) in Table 1, was retrieved from Hiatt and Grady (2008). 234 
Xbiomass (gbiomass L
-1
) denoted the biomass concentration in the MBBRs and growth of biomass on 235 
micropollutants was considered negligible.  236 
 237 
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Biotransformation constants kbio (process 2, Table 1) were estimated from the measured data using 238 
least-square optimization without weighting in GraphPad Prism 5.0. Parent compound 239 
retransformation and cometabolism model (processes 1 and 3, Table 1) were implemented in 240 
AQUASIM 2.1d (Reichert et al., 1994) and the parameters were estimated using the secant method 241 
embedded. 242 
Removal rate constants k (d
-1
) were also estimated to compare the performance of the two MBBR 243 
systems, regardless of biomass concentration and sorption processes (Escolà Casas et al., 2015a,b). 244 
For the chemicals following cometabolism model (and thus exhibiting two biokinetics), k was 245 
calculated considering the estimated qbio. Differences between biotransformation rate constants of 246 
the two MBBRs were assessed by examining the overlap between standard deviations of the 247 
estimated values (Cumming et al., 2007). 248 
 249 
2.5 DNA extraction, PCR amplification, sequencing and bioinformatics analysis. 250 
One carrier was collected from each MBBR before the batch experiment and stored in a sterilized 251 
Eppendorf tube at -20 
o
C. Biomass was detached using a sterile brush (Gynobrush, Dutscher 252 
Scientific, United Kingdom) using tap water and consequently centrifuged (10000 rpm for 5 253 
minutes) to remove excess water. DNA extraction, PCR amplification (using 16S rRNA bacteria 254 
gene primers) and Illumina sequencing were performed as described in Section S5 of the SI. 255 
Taxonomic assignment and calculation of alpha diversity metrics (Shannon biodiversity and ACE 256 
extrapolated richness) were performed in mothur using the RDP reference taxonomy. Additional 257 
diversity indices were calculated according to Hill et al. (1973). Microbial evenness was estimated 258 
as H1/H0 as described in Johnson et al. (2015). 259 
  260 
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2.6 Continuous-flow experiment  261 
The two MBBRs used for the present study were operated for over 4 months. The MBBRs were 262 
kept with a CODadded/NO3-Ninfluent ratio equal to 3 (close to the ratios used at the respective 263 
WWTPs) for the first two weeks of operation. The fraction of inert COD was taken into account (by 264 
subtracting it from the amount of available biodegradable COD) when planning experiments under 265 
carbon limitation. A hydraulic retention time (HRT) of 2 hours was set similar to the HRT used at 266 
the full-scale WWTPs. After two weeks of acclimatization, baseline carbon-dosage periods of 267 
CODadded/NO3-Ninfluent were alternated with short carbon-dosage periods (~5 days) to avoid biomass 268 
adaptation. Accordingly, concentrations of methanol and ethanol in the feed solutions were changed 269 
to test CODadded/NO3-Ninfluent ratios ranging from 1 to 5, while keeping constant HRT. This test 270 
phase lasted about 2 months. The CODadded/NO3-Ninfluent ratios and the dates are reported in the 271 
Table S3 (SI). The range of CODadded/NO3-Ninfluent ratios was chosen to assess carbon limiting 272 
condition at low CODadded/NO3-Ninfluent ratio and not far exceeding the stoichiometric 273 
CODadded/NO3-Ninfluent ratio needed for complete denitrification. The denitrification rate rD (gN d
-1
 274 
m
-2
) in continuous operation, was calculated for each carbon-dosage test by using the Equation S1 275 
(Section S6, SI). Micropollutant removal efficiency (“measured removal” in Figure 4) was 276 
calculated as difference between inlet and outlet concentrations. Micropollutant removal efficiency 277 
during continuous operation (“predicted removal” in Figure 4) was predicted using removal rate 278 
constant k (d
-1
) estimated during batch experiment according to Equation 1: 279 
                
 
          
       Equation 1 280 
281 
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3. Results and discussion 282 
 283 
3.1 Batch experiment  284 
 285 
3.1.1 Denitrification kinetics 286 
Denitrification rates (rNO3,2-N, kNO3,2-N) were derived through linear regression of measured NO3
−
-N 287 
and NO2
−
-N concentration during batch experiment (Figure S5, SI). The ethanol-dosed reactor 288 
presented a higher surface-normalized denitrification rate rNO3,2-N (Table 2) than the methanol driven 289 
one, which is in agreement with previous studies (Santos et al., 2001; Christensson et al., 1994). 290 
This is likely due to the higher growth yield expected using ethanol thereby leading to higher 291 
biomass production per surface area in ethanol-dosed systems (Mokhayeri et al., 2009). On the 292 
other hand, denitrification rates (kNO3,2-N) normalized by biomass weight (higher for the ethanol-293 
dosed reactor) were comparable in the two MBBRs, suggesting similar activity in terms of nitrate 294 
and nitrite removal in the two biofilms. 295 
 296 
3.1.2 Micropollutant removal kinetics  297 
Biotransformation kinetics of most of the investigated chemicals could be described with first-order 298 
equation (Table 1, process 2), thereby allowing for the estimation of removal rates k (d
-1
) and 299 
pseudo-first order biotransformation rate constants kbio (L gbiomass
-1
 d
-1
). Abiotic transformation 300 
processes were previously investigated by the authors using plastic (polyethylene) carriers 301 
(AnoxKaldnes Z-carriers) and effluent wastewater (Torresi et al., 2016), suggesting no significant 302 
impact of abiotic processes (e.g., abiotic hydrolysis, volatilization, sorption onto plastic or glass) on 303 
the removal of several targeted micropollutants (Figure S9). Figures 1 and S1 summarize measured 304 
and simulated micropollutant concentration profiles during batch experiments.  305 
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The removals of erythromycin, clarithromycin, venlafaxine, carbamazepine, sulfamethoxazole and 306 
sulfamethizole was predicted using (i) a pseudo-first order biotransformation model (Table 1, 307 
process 2), with no interaction (inhibition/enhancement) between micropollutant and primary 308 
substrate; and (ii) additionally, a cometabolic model (Table 1, process 3), assuming that the 309 
turnover of the micropollutants is enhanced by the presence of primary substrate. Predictions with 310 
the two models are presented in Figure 1b–d using dashed lines and solid lines, respectively. The 311 
goodness of the two model fits (R
2
) is summarized in Table S4 (SI). For erythromycin and 312 
clarithromycin, the cometabolic model (R
2
 > 0.9) provided only for a marginal improvement of the 313 
fitting compared to the pseudo-first order biotransformation model (R
2
 > 0.8), making it difficult to 314 
draw conclusion on the removal mechanism of these two compounds. However, the prediction of 315 
carbamazepine’s removal was significantly improved by adopting the cometabolic model (R2 > 0.9) 316 
compared to the pseudo first-order biotransformation model (R
2
 < 0.5) in both MBBRs. 317 
Cometabolic biotransformation of carbamazepine has been previously observed in aerobic and 318 
anoxic activated sludge (Plósz et al., 2012) with cometabolic biotransformation rate constant qbio 319 
(1.2 L g
-1
 d
-1
 under anoxic condition), in close agreement with our results. Similarly, the removal of 320 
venlafaxine, sulfamethoxazole and sulfamethizole removal was better predicted using the 321 
cometabolic model (R
2 
> 0.9). In Figure 1a, the measured and simulated concentration of soluble 322 
COD (sCOD), nitrate (NO3-N) and nitrite (NO2-N) and simulated readily biodegradable COD (SS) 323 
are reported. For the abovementioned micropollutants, SS limitation (approximately after 3 hours 324 
from the beginning of the experiment) corresponded to a change in biotransformation kinetics. 325 
Interestingly, in the ethanol-fed reactor, the modelled SS limitation coincided with a significant 326 
decrease in the biotransformation rates of sulfamethoxazole and sulfamethizole (Figure 1d right), 327 
thereby leading to a rather low removal rate during the rest of the experiment. A similar effect for 328 
both compounds, though at lower extent, was observed for the methanol-dosed reactor. 329 
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Cometabolic transformation of trace chemicals was previously shown in suspended cultures under 330 
aerobic, anaerobic and anoxic conditions (Delgadillo-Mirquez et al., 2011; Fernandez-Fontaina et 331 
al., 2014; Plósz et al., 2010; Popat and Deshusses, 2011; Tran et al., 2013). Removal via 332 
cometabolism was previously observed for sulfamethoxazole in nitrifying (Kassotaki et al., 2016; 333 
Müller et al., 2013) and in aerobic and anoxic activated sludge (Alvarino et al., 2016), as well as for 334 
erythromycin and roxithromycin (Fernandez-Fontaina et al., 2014) in nitrifying activated sludge. 335 
Thus, our results support the hypothesis that the change of primary substrate availability can 336 
significantly impact the removal of a number of micropollutants as a result of cometabolic 337 
mechanisms under denitrifying conditions.  338 
 339 
While the other sulfonamides followed cometabolic biotransformation, the removal of sulfadiazine 340 
was different. It could not be described with first-order kinetics (R
2 
< 0.2 and < 0.4 for methanol- 341 
and ethanol-dosed MBBR respectively, dashed lines in Figure 1 e), due to the presence of its 342 
conjugate acetyl-sulfadiazine. Acetyl-sulfadiazine is the main human metabolite of sulfadiazine 343 
(Vree et al., 1995) and it has been previously observed to undergo de-acetylation (Zarfl et al., 344 
2009), similarly to other acetyl-sulfonamides such as N
4
-acetylsulfamethoxazole (Göbel et al., 345 
2007). For these chemicals, a model including retransformation (deconjugation) of acetyl-346 
sulfadiazine to sulfadiazine and concurrent biotransformation of sulfadiazine was used to estimate 347 
biotransformation rate constants kbio for sulfadiazine and retransformation rate constant kDec for 348 
acetyl-sulfadiazine (Table 1, processes 1 and 2). However, this modelling approach did not 349 
adequately describe the concentration changes of sulfadiazine in any of the MBBRs (R
2
 < 0.2, 350 
continuous lines in Figure 1e):  351 
For the methanol-dosed MBBR, acetyl- sulfadiazine was decreasing rapidly and sulfadiazine (being 352 
formed from acetyl-sulfadiazine) reached a maximum before being slowly further biotransformed 353 
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(Figure 1e left). In the ethanol-dosed MBBR, the acetyl-sulfadiazine was also rapidly removed and 354 
sulfadiazine concentration did never increase. Thus, for the ethanol-dosed reactor there is no 355 
indication for a deconjugation reaction of acetyl-sulfadiazine to sulfadiazine, while that is partially 356 
possible in the methanol-dosed one. Hence, the transformation of acetyl-sulfadiazine probably 357 
occurred partially following another metabolic pathway leading to the formation of other 358 
(undetected) transformation products. To test whether other pathways could be possible, the 359 
EAWAG-BBD pathway prediction systems (EAWAG-BBD, 2016) was used: It showed the 360 
possible transformation of acetyl-sulfadiazine to other transformation products, e.g., 2-361 
aminopyrimidine and 4-aminobenzenesulfonic acid (Figure S6, SI). However, additional research 362 
on the different transformation pathways of acetyl-sulfadiazine in the two tested MBBRs is needed 363 
to substantiate this hypothesis. Further discussion on the biotransformation of acetyl-sulfadiazine 364 
and sulfadiazine in the two investigated MBBRs is reported in S4 in SI.   365 
 366 
 367 
3.2. Influence of dosed carbon-source on microbial communities 368 
We analyzed the biofilm microbial community of the two different MBBRs by 16S rRNA amplicon 369 
sequencing. After implementation of quality control measures, a total of 10847 high quality 370 
sequences were obtained with an average length of 460 bp. Subsequently, the number of reads of 371 
each sample was normalized to 4562 sequences and clustered into an average of 690 observed 372 
OTUs at 97% sequence similarity per sample (cut-off level of 3%). The facultative methanol-373 
utilizing β-Proteobacteria, Methylophilus, was identified as the main relative abundance genus 374 
(24%) in the methanol-dosed reactor (Figure 2)—a result that closely agreed with previous studies 375 
on methanol-dosing denitrification systems (Baytshtok et al., 2009; Jenkins et al., 1987; Lu et al., 376 
2014). For the biofilm grown in the ethanol-dosed reactor, Arcobacter and Thiothrix genus 377 
exhibited 23% and 9% relative abundance, respectively. Arcobacter was previously identified in 378 
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full-scale MBBRs treating municipal wastewater (Biswas and Turner, 2012). Thiothrix is known to 379 
degrade sulfur containing compounds and it was suggested to influence the removal of sulfa-based 380 
antibiotics in membrane bioreactors (Xia et al., 2012). Microbial community diversity in the two 381 
MBBRs was evaluated by comparing Shannon diversity and evenness indices. We observed no 382 
major difference in the methanol- and ethanol-dosed reactors between Shannon diversity indices 383 
(4.153 ± 0.05 and 4.184 ± 0.03, mean and standard deviation, respectively) and evenness (0.092 ± 384 
0.002 and 0.095 ± 0.001, respectively) (Figure 2, Table S5 of the SI). Similar values of Shannon 385 
diversity indices were found previously in aerobic nitrifying MBBRs (Bassin et al., 2015; Torresi et 386 
al., 2016). On the other hand, the extrapolated taxonomic richness ACE in the methanol- and 387 
ethanol-dosed reactors were estimated to be 999 ± 103 and 781 ± 87 OTUs, respectively, thus 388 
suggesting slightly differences between the microbial richness of the two biofilms (Figure 2). 389 
Similar evidence was obtained from nitrite reductase nirK- and nirS-based restriction fragment 390 
length polymorphism (RFLP) analysis on activated sludge supplemented with methanol or ethanol, 391 
with higher diversity in terms of richness of nirS genotypes observed in the methanol-dosed sludge 392 
(Hallin et al., 2006).  393 
 394 
3.3. Influence of dosed carbon source on micropollutants biotransformation  395 
A comparative assessment of the estimated kbio, qbio and kDec values for the methanol- and ethanol-396 
dosed MBBRs is shown in Figure 3. For 9 compounds the estimated values of biotransformation 397 
and cometabolic transformation rate constants (kbio and qbio) for the methanol-dosed MBBR were 398 
higher (1.5 to 2.5-fold) than those from the ethanol-dosed reactor (namely atenolol, citalopram, 399 
trimethoprim, ibuprofen, iopromide, metoprolol, iohexol, iomeprol, sotalol, venlafaxine). 400 
Conversely, the sulfonamides acetyl-sulfadiazine, sulfamethoxazole, sulfamethizole were 401 
transformed at higher rate constants (up to 2.8-fold) in the ethanol-dosed reactor. The remaining 10 402 
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compounds behaved similarly in both reactors. We further classified the biotransformation potential 403 
of the targeted micropollutants of the two denitrifying MBBRs in three groups (Table 3): easily 404 
degradable (qbio and kbio > 2), moderately degradable (0.2≤ kbio and qbio ≥2) and hardly degradable 405 
(kbio and qbio < 0.2).  406 
We observed that some of the targeted chemicals classified as easily degradable (propranolol, 407 
atenolol, citalopram) presented removal rate constant k (d
-1
) above 10 d
-1 
and similar between the 408 
two MBBRs (Table 3). As the two MBBRs presented different amount of biomass (Table 2) during 409 
batch experiment, the lower values of kbio for the high degradable compounds in the ethanol-dosed 410 
reactor could mainly derive from the normalization to a higher amount of biomass prevailing in the 411 
ethanol-dosed reactor.  412 
On the other hand, a number of moderately degradable chemicals (i.e., X-ray contrast media, 413 
ibuprofen, metoprolol and sotalol) were associated to k and kbio values approximately two times 414 
higher in the methanol-dosed than in the ethanol-dosed reactor. The two biofilm microbial 415 
communities likely played an important role on the biotransformation of these chemicals. As 416 
previously described (Section 3.2), the higher microbial richness observed in the biofilm enriched 417 
with methanol could have likely contributed to the overall higher micropollutant biotransformation 418 
in the methanol-dosed MBBR. Similarly, positive associations between biodiversity and the rates of 419 
specific micropollutant biotransformations were observed in activated sludge (Johnson et al., 2015; 420 
Stadler and Love, 2016) and MBBR (Torresi et al., 2016).   421 
No major differences were observed between the biotransformation rate constants kbio of the hardly 422 
degradable compounds (diatrizoic acid, iopamidol, diclofenac and phenazone) in the two MBBRs, 423 
suggesting that their removal is neither biomass nor carbon source dependent.  424 
  425 
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3.4 Highlighted compounds 426 
Among the X-ray contrast media, iopamidol and diatrizoic acid were found to be recalcitrant in both 427 
reactors during batch experiment (Figure S1, SI), while iomeprol, iohexol and iopromide were 428 
found moderately degradable (Figure 1d). These results are in agreement with previous studies 429 
conducted with aerobic MBBRs (Escolà Casas et al., 2015a; Hapeshi et al., 2013). Our results show 430 
that denitrifying MBBRs could effectively remove iomeprol, iohexol and iopamidol, with kbio 431 
comparable to studies on activated sludge (Joss et al., 2006; Onesios et al., 2009)  432 
The analgesic ibuprofen exhibited lower biotransformation rate constants (Table 3) than the ones 433 
obtained in previous studies under aerobic conditions (Escolà Casas et al., 2015a,b; Falås et al., 434 
2012; Torresi et al., 2016) as ibuprofen is easily degraded under aerobic conditions. Other 435 
analgesics, i.e., phenazone and diclofenac, have also previously observed to be hardly degradable in 436 
both aerobic MBBR and activated sludge (Escolà Casas et al., 2015a; Joss et al., 2006). 437 
Nevertheless, kbio values for diclofenac were reported to be higher under nitrifying conditions in 438 
both biofilms and activate sludge (Torresi et al., 2016; Tran et al., 2009) than as obtained in this 439 
study under denitrifying conditions, thus indicating limited diclofenac removal under anoxic 440 
conditions. 441 
 442 
In the batch experiment, citalopram was fully removed in both reactors within 0.4 days (Figure 1b), 443 
resulting in a kbio of 2.3 L d
−1
 gbiomass
−1
 (Table 3). Similar biotransformation kinetics was found in 444 
aerobic MBBR (Escolà Casas et al., 2015a) and sludge (Suárez et al., 2012), while anoxic CAS 445 
showed lower kientics compared to the one obtained in th anoxic MBBRs of this study. At HRTs 446 
higher than 0.4 days, a removal efficiency of 65% was achieved in a complete autotrophic nitrogen 447 
removal process (Alvarino et al., 2015). In our study, predicted removal efficiency of citalopram (at 448 
HRT of 0.4 days) was calculated to be >80% in both reactors (Equation 1) during continuous-flow 449 
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operation. Furthermore, in denitrifying activated sludge reactors a kbio of 0.5 L d
−1
 gbiomass
−1 
was 450 
obtained for citalopram (Suárez et al., 2010) and a removal of 44 % under anoxic condition (Suárez 451 
et al., 2010). 452 
 453 
The removal of carbamazepine and venlafaxine (with qbio ranging between 1.1 and 1.9 L g
-1
 d
-1
) 454 
followed the kinetics described by the cometabolic model in our study, as suggested previously (see 455 
Section 3.1.2). With respect to biotransformation kinetics, only one study showed cometabolic 456 
biotransformation rate constants of up to 2 L g 
-1
 d
-1
 for carbamazepine in aerobic and anoxic 457 
activated sludge (Plósz et al., 2012). On the other hand biotransformations rate constants equal to 458 
0.9 L g
-1
 d
-1
 in aerobic MBBR have been reported (Escolà Casas et al., 2015a). In our study we thus 459 
observed 30 % removal of carbamazepine during batch experiments, which is in agreement with 460 
previous studies on MBBR (Escolà Casas et al., 2015a) and activated sludge (Dawas-Massalha et 461 
al., 2014; Luo et al., 2014; Zupanc et al., 2013). Thus, low removal of carbamazepine in the tested 462 
MBBRs in batch and continuous-flow experiments may be attributed to the limited transformation 463 
in the absence of primary substrates. 464 
 465 
The biotransformation of the targeted sulfonamides was enhanced in the ethanol-dosed MBBR (up 466 
to 1.8-fold higher). As the ethanol-dosed MBBR showed the highest denitrification rates (rNO3,2-N) 467 
during the batch experiment, the removal of the targeted sulfonamides may be associated with 468 
primary metabolism rather than biofilm composition (i.e., biodiversity). Interestingly, negative 469 
correlation between biotransformation kinetics of sulfonamides and biodiversity was also observed 470 
in nitrifying MBBRs, and their removal was enhanced at higher nitrification rates in thin biofilms 471 
(Torresi et al., 2016). Similarly, the removal of sulfamethoxazole has been previously shown to be 472 
dependent on the primary metabolism under anoxic condition in activated sludge, while negligible 473 
 22 
 
effect of primary substrate was observed under nitrifying condition (Alvarino et al., 2016). This 474 
indicates that sulfonamide removal may be influenced by primary metabolism in both nitrifying and 475 
denitrifying conditions. 476 
 477 
Finally, while kbio of clarithromycin and erythromycin was found comparable to studies on aerobic 478 
MBBRs (Escolà Casas et al., 2015a), trimethoprim removal occurred with a higher kbio under 479 
denitrification conditions than in aerobic MBBRs (Escolà Casas et al., 2015a; Falås et al., 2013). 480 
 481 
3.5 Impact of carbon dosing during continuous-flow operation  482 
A continuous-flow experiment tested different dosing conditions of organic carbon in terms of 483 
primary substrate (methanol or ethanol) and influent loading (variable CODadded/NO3-Ninfluent ratio) 484 
without adaptation of the biofilm as described in Section 2.6 (details in Section S7, SI). The 485 
removal efficiency of micropollutants did not present any correlation with the tested CODadded/NO3-486 
Ninfluent ratios and did not significantly differ between the two types of carbon sources (Figure S8, 487 
SI). Notably, only trimethoprim removal increased with increasing carbon availability in the 488 
ethanol-dosed reactor. 489 
 490 
Both MBBR systems exhibited denitrification rates directly proportional to the CODadded/NO3-491 
Ninfluent ratio (Figure S3, SI). However, at CODadded/NO3-Ninfluent ratios higher than 4.8 and 3.8 for 492 
the methanol- and the ethanol-dosed MBBR, respectively, denitrification rates did not increase and 493 
similar effluent concentrations of COD were measured for both MBBRs (estimated to be equal to 494 
the inert soluble COD in the influent medium) (Figure S4, SI). This indicates that excess COD 495 
dosing during continuous-flow operation could have been used for internal storage rather than as 496 
primary energy source. This has been previously observed under substrate feast-famine cycles in 497 
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continuously operated activated sludge (Beun et al., 2000). Similarly, feast-famine conditions 498 
associated to change from high to low CODadded/NO3-Ninfluent ratio during continuous-flow operation 499 
might have influenced the performance of the two post-denitrifying MBBRs in this study.   500 
 501 
Furthermore, the continuous-flow operation experiment was carried out at HRT of 2 h, simulating 502 
HRTs typically operated in denitrification stages in full scale WWTPs, and which might have been 503 
too short to observe differences in the removal of micropollutants. In fact, the batch experiment 504 
showed that the removal of most of the targeted micropollutants (with the exception of the 505 
compounds removed through cometabolism) continued after 2 h from the start of the experiment 506 
(Figure 1), suggesting a possible removal enhancement at higher HRT. Accordingly, the increase of 507 
HRT has been found to enhance the removal of a number of micropollutants in activated sludge 508 
(Maurer et al., 2007; Petrie et al., 2014) and MBBR (Mazioti et al., 2015). 509 
 510 
3.6. Comparison of the batch and the continuous-flow experiment 511 
Figure 4 compares the measured removal efficiencies under continuous –flow operation with the 512 
predicted removal efficiencies. The predicted values were calculated using the removal rates (k) 513 
estimated in the batch experiment according to first-order kinetics (Table 3). As presented in Figure 514 
4, the removal rates (k) estimated from batch experiments allowed predicting of the elimination of 515 
most of the targeted compounds in continuous-flow operation. However, predicted removal 516 
efficiencies did not match the measurements for a number of micropollutants, i.e. sulfamethoxazole, 517 
carbamazepine, atenolol and trimethoprim. A possible explanation for this discrepancy might be 518 
that the removal rates (k) used to predict the removals were obtained by fitting the first order 519 
kinetics, while in reality for some compounds cometabolic or deconjugation approaches are more 520 
appropriate.  521 
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 522 
As the biotransformation kinetics of most of the compounds could be described with a first-order 523 
equation (Table 1, process 2 and Figure 1), it could be predicted that an HRT of 2 h (0.083 d) would 524 
only allow a partial removal of the easily biodegradable compounds (e.g., atenolol, trimethoprim 525 
and citalopram)  in the continuous-flow experiment (Figure 4). For the compounds following this 526 
type of biotransformation kinetics, it could be predicted (Equation 1, Section 2.6) that the increase 527 
of the HRT up to 6 hours (0.25 d) would improve the removal efficiency by about 20%, achieving 528 
high removals in both reactors (>70%) for all the compounds listed as “easily biodegradable” in 529 
Table 3. 530 
 531 
4. Conclusions 532 
In order to investigate the removal of micropollutants in denitrifying Moving Bed Biofilm Reactors 533 
(MBBRs), two laboratory-scale MBBRs were tested using nitrified effluent wastewater dosed with 534 
methanol and ethanol, respectively. The following conclusions have been drawn: 535 
 536 
 According to the batch experiment, all targeted micropollutants showed biotransformation rate 537 
constants over 0.2 L d
-1
gbiomass
-1
 under denitrifying condition, except for diclofenac, phenazone, 538 
diatrizoic acid and iopamidol, which were found to be recalcitrant. Accordingly, it has been 539 
suggested that that HRTs of approximately 6 h could considerably enhance the removal of most 540 
of the targeted micropollutants.  541 
 542 
 The biotransformation rate constants in the methanol-dosed MBBR were 1.5 to 2.5-fold higher 543 
than in the ethanol-dosed MBBR for 9 out of the 22 spiked pharmaceutical. Oppositely, the 544 
sulfonamides acetyl-sulfadiazine, sulfamethoxazole, sulfamethizole were transformed at higher 545 
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biotransformation rate constants in the ethanol-dosed MBBR. The rest of the compounds 546 
presented similar biotransformation in both reactors. 547 
 548 
 The removal of venlafaxine, carbamazepine, sulfamethoxazole and sulfamethizole was most 549 
likely enhanced by the presence of organic growth substrates in the beginning of the batch 550 
experiment, suggesting cometabolic removal for these compounds. 551 
 552 
 The continuous-flow experiment conducted at conditions typically operated in full-scale 553 
WWTPs (i.e., HRT =2h) did not show significant correlation between the removal efficiency of 554 
micropollutants and the increase of carbon dosage or type.  555 
 556 
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Tables 762 
Table 1. Stoichiometric (Gujer) matrix of the ASM-X (which includes processes such as parent 763 
compound retransformation, biotransformation and the cometabolic model) and two-step denitrifying 764 
model used in this study. 765 
Stoichiometric coefficients: A= (1-YH)/(1.143 * YH); B = (1-YH)/(1.713 * YH); F = ratio between molecular 766 
mass of parent compound and metabolite undergoing deconjugation. Parameters and state variables 767 
for determination of micropollutant kinetics are described in the main text. Parameters and state 768 
variables for the denitrifying model are defined in Table S1 in Supplementary Information. For 769 
estimation of denitrification kinetics, biomass concentration XH is expressed in gCOD L
-1
; *Due to 770 
short duration of the batch experiment and low S/X ratio, negligible biomass growth was assumed. 771 
 772 
(i) Component → i CLI CCJ SNO3 SNO2 SN2 Ss Xbiomass 
Process rate 
(j)Processes ↓        
 Micropollutants kinetics  
(1)
Parent compound 
retransformation 
F -1      
biomassD
biomassCJDec
XK
XCk
1
 
(2)
Biotransformation -1       
biomassD
biomassLIbio
XK
XCk
1
 
(3)
Cometabolism -1       
biomassLI
biomassD
bioSbio XC
XK
kKq


1
))Ss(Ss/(  
 Denitrification kinetics  
R1   -A +A  -1/YH *        
  
      
    
    
       
 
R2    -B +B -1/YH *        
  
      
    
    
       
 
R1: Anoxic growth of heterotrophs, reducing nitrate to nitrite (NO3
-
 ->  NO2
-
) 
 
R2: Anoxic growth of heterotrophs, reducing nitrite to nitrogen (NO2
-
 ->  N2) 
 
 
 773 
  774 
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Table 2. Values of denitrification rates normalized by carriers surface area (rNO3,2-N) and biomass 775 
concentration (kNO3,2-N) measured during batch experiments. SA: total surface area of carriers in the 776 
MBBRs. 777 
 778 
MBBR 
SA 
(m
2
) 
Biomass 
(g L
-1
) 
rNO3,2-N 
(gNO3,2-N m
-2
 d
−1
) 
kNO3,2-N 
(gNO3,2-N gbiomass
-1
 d
−1
) 
Methanol-dosed 0.2 3.28 ±0.93 1.77 ± 0.92 0.11 ± 0.06 
Ethanol-dosed 0.2 4.20 ±0.25 2.32 ± 0.62 0.11 ± 0.03 
 779 
  780 
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Table 3. Values of k, kbio, qbio and kDec estimated for the two MBBRs from the data obtained in the 781 
batch experiments. “k” defines the removal rate constant obtained following single first-order 782 
kinetics and not accounting for biomass concentration and sorption processes. “kbio” and “qbio” refer 783 
to removal rate constants normalized for biomass and sorption processes. Unindexed values 784 
correspond to “kbio” (Biotransformation process, Table 1, Process 2). Index (1) indicates the case of 785 
retransformation rate constant “kDec” of acetyl-sulfadiazine to sulfadiazine (Transformation process, 786 
Table 1, Process 1). Index (2) refers to the cometabolic rate constant “qbio” (Cometabolism, Table 1, 787 
Process 3). The following abbreviations are used: n.d. = not degradable, SD =standard deviation. 788 
 789 
   Methanol-dosed MBBR Ethanol-dosed MBBR 
Compound 
k ± SD  
(d
-1
) 
kbio, qbio ± SD 
(L d
-1
gbiomass
-1
) 
k ± SD 
(d
-1
) 
kbio, qbio ± SD 
(Ld
-1
gbiomass
-1
) 
Easily degradable; kbio, qbio >2                                   
Propranolol 17.8 ± 0.2  12.9 ± 1.3 17.7 ± 0.2           11.7 ± 0.7  
Atenolol 17.8 ± 0.2    6.4 ± 0.6 17.6 ± 0.2 5.1 ± 0.3 
Citalopram 14.2 ± 0.9    4.3 ± 0.5 12.3 ± 0.1 2.3 ± 0.1 
Trimethoprim 13.6 ± 0.1    4.1 ± 0.4  9.0  ± 0.1 2.1 ± 0.1 
Acetyl-sulfadiazine 12.1± 0.3       3.7 ± 0.4
 (1)
    17.6 ± 0.2   4.2 ± 0.3
 (1)
  
Moderately degradable; 0.2 ≤ kbio, qbio ≤2                             
Ibuprofen 4.6 ± 0.1  1.4 ± 0.4 2.3 ± 0.1
 
    0.5 ± 0.03
 
  
Clarithromycin 2.9 ± 0.7 
    1.0 ± 0.2
 (2)
 
 0.6 ± 0.1
 
  
4.4 ± 0.9
 
  
   0.9 ± 0.2
(2)  
 
 
          0.4 ± 0.1
 
    
Iopromide 3.0 ± 0.1  0.9 ± 0.1 1.7 ± 0.1
 
    0.4 ± 0.1
 
    
Metoprolol 2.6 ± 0.1  0.8 ± 0.2 1.7 ± 0.1
 
      0.4 ± 0.03
 
    
Iohexol 2.3 ± 0.1  0.7 ± 0.2 1.2 ± 0.1
 
    0.3 ± 0.1
 
    
Iomeprol 2.1 ± 0.1  0.6 ± 0.1 1.2 ± 0.1
 
    0.3 ± 0.1
 
    
Sotalol 1.3 ± 0.1  0.5 ± 0.1 0.7 ± 0.1
 
      0.2 ± 0.02
 
    
Erythromycin 1.5 ± 0.1 
    0.5 ± 0.1
 (2)
 
 0.2 ± 0.1 
2.5 ± 0.1
 
    
   0.6 ± 0.1
(2) 
  
0.2 ± 0.1
 
    
Venlafaxine 6.0 ± 0.1 
    1.9 ± 0.2
 (2)
 
0.1 ± 0.1 
4.8 ± 0.1
 
    
   1.1 ± 0.1
(2)
 
0.1 ± 0.1
 
          
Carbamazepine 3.9 ± 0.1 
   1.2 ± 0.3
 (2)
 
0.1 ± 0.1   
4.6 ± 0.1
 
    
   1.1 ± 0.1
(2)
 
          0.1 ± 0.1
 
    
Sulfamethoxazole 5.6 ± 0.8 
   1.7 ± 0.2
 (2)
 
0.1 ± 0.1   
13.5 ± 0.7
 
    
    3.2 ± 0.2
 (2)
 
0.1 ± 0.1
 
          
Sulfamethizole  5.8 ± 0.9 
   1.8 ± 0.2
 (2)
 
0.1 ± 0.1   
13.8 ± 0.8
 
    
    3.3 ± 0.2
 (2)
  
0  
Sulfadiazine 1.9 ± 0.2 0.6 ± 0.1     4.2 ± 0.6
 
    1.0 ± 0.2 
Hardly or non-degradable; kbio, qbio <0.2                                   
Diatrizoic acid 0.3 ± 0.1 0.1 ± 0.02  0.1 ± 0.1 0.1 ± 0.1 
Iopamidol 0.2 ± 0.1 0.1 ± 0.02 0.1 ± 0.1 0.1 ± 0.1 
Diclofenac n.d. n.d. n.d. n.d. 
Phenazone n.d. n.d. n.d. n.d. 
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Figures 791 
 792 
Figure 1. Batch experiment results for selected compounds. On the X-axes “Time (d)” designates the sampling 793 
time-points. On the Y-axes “Relative concentration” refers to concentrations normalized to the measured 794 
starting concentrations. Symbols refer to measurements while lines refer to modelling. [a] Macro-pollutants. 795 
Readily biodegradable substrate (SS) is only modelled. [b-d] Solid lines: modelled concentrations assuming 796 
cometabolism (process 3, Table 1). Dashed lines: concentrations according to the biotransformation model 797 
(process 2, Table 1). [e] Solid lines: biotransformation-retransformation model (process 1, Table 1) assuming 798 
deconjugation of acetyl-sulfadiazine to sulfadiazine. Dashed lines: biotransformation model (process 2, Table 799 
1),. [f] Solid lines: concentrations according to the biotransformation model (process 2, Table 1). 800 
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 802 
 803 
Figure 2. Order-level taxonomic classification of 16S rRNA amplicons of the two MBBRs. The three 804 
most abundant orders are reported also at genus level (Methylophiulus, Arcobacter and Thiotrix). 805 
Taxa abundance is expressed in percentage (second left axis). Alpha-diversity is measured as ACE 806 
extrapolated richness (first left axis) and Shannon diversity index (right axis).  807 
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 809 
 810 
Figure 3. Comparative assessment between methanol-dosed reactor (x-axes) and the ethanol-dosed 811 
reactor (y-axes) of the removal kinetics kbio, qbio and kDec estimated for all targeted compounds (a) and 812 
for compounds with biokinetics ranging between 0 and 2 L gbiomass
-1 
d
-1
 (b). Dashed lines (2:1 and 1:2) 813 
delimit area where biokinetics are 2-folder higher or lower than other estimated values. In the legend, 814 
when not specified, symbols refer to estimated kbio. 815 
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 817 
 818 
Figure 4. Measured mean removal efficiency of micropollutants of all the tested CODadded/NO
3
-N 819 
influent ratios (presented in Table S3, SI) during the whole continuous-flow experiment, taking into 820 
account that no correlation was found between micropollutant removal and CODadded/NO
3
-N influent 821 
ratios. The measured removals were calculated as difference between influent and effluent 822 
concentration, expressed as a percentage. Predicted removal was based on removal rate constants k 823 
(d
-1
) derived from batch experiments, calculated according to Equation 1 in Section 2.6. 824 
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